Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial

Introduction Real-time continuous glucose monitoring (rt-CGM) informs users about current interstitial glucose levels and allows early detection of glycaemic excursions and timely adaptation by behavioural change or pharmacological intervention. Randomised controlled studies adequately powered to evaluate the impact of long-term application of rt-CGM systems on the reduction of adverse obstetric outcomes in women with gestational diabetes (GDM) are missing. We aim to assess differences in the proportion of large for gestational age newborns in women using rt-CGM as compared with women with self-monitored blood glucose (primary outcome). Rates of neonatal hypoglycaemia, caesarean section and shoulder dystocia are secondary outcomes. A comparison of glucose metabolism and quality of life during and after pregnancy completes the scope of this study. Methods and analysis Open-label multicentre randomised controlled trial with two parallel groups including 372 female patients with a recent diagnosis of GDM (between 24+0 until 31+6 weeks of gestation): 186 with rt-CGM (Dexcom G6) and 186 with self-monitored blood glucose (SMBG). Women with GDM will be consecutively recruited and randomised to rt-CGM or control (SMBG) group after a run-in period of 6–8 days. The third visit will be scheduled 8–10 days later and then every 2 weeks. At every visit, glucose measurements will be evaluated and all patients will be treated according to the standard care. The control group will receive a blinded CGM for 10 days between the second and third visit and between week 36+0 and 38+6. Cord blood will be sampled immediately after delivery. 48 hours after delivery neonatal biometry and maternal glycosylated haemoglobin A1c (HbA1c) will be assessed, and between weeks 8 and 16 after delivery all patients receive a re-examination of glucose metabolism including blinded CGM for 8–10 days. Ethics and dissemination This study received ethical approval from the main ethic committee in Vienna. Data will be presented at international conferences and published in peer-reviewed journals. Trial registration number NCT03981328; Pre-results.

[1]  P. Georgiou,et al.  Assessment of Glucose Control Metrics by Discriminant Ratio. , 2020, Diabetes technology & therapeutics.

[2]  Intrauterine Exposure , 2020, Definitions.

[3]  A. Tura,et al.  Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index , 2018, Diabetologia.

[4]  Michelle Perkins,et al.  Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial , 2017, The Lancet.

[5]  13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[6]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[7]  David C Klonoff,et al.  Continuous glucose monitoring: A review of the technology and clinical use. , 2017, Diabetes research and clinical practice.

[8]  P. Valensi,et al.  Poor Reliability and Poor Adherence to Self-Monitoring of Blood Glucose Are Common in Women With Gestational Diabetes Mellitus and May Be Associated With Poor Pregnancy Outcomes , 2017, Diabetes Care.

[9]  Sarit Polsky,et al.  CGM, Pregnancy, and Remote Monitoring. , 2017, Diabetes technology & therapeutics.

[10]  K. Shankar,et al.  Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child , 2017, British Medical Journal.

[11]  C. Cobelli,et al.  Liver triacylglycerol content and gestational diabetes: effects of moderate energy restriction , 2016, Diabetologia.

[12]  Eman M. Alfadhli,et al.  Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes , 2016, Diabetology & Metabolic Syndrome.

[13]  S. Edelman,et al.  Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes , 2016, Journal of diabetes science and technology.

[14]  Zi-lin Sun,et al.  Effect of a CGMS and SMBG on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus: a Randomized Controlled Trial , 2016, Scientific Reports.

[15]  D. Feig,et al.  Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy , 2015, Diabetes Care.

[16]  Jong-Hee Hwang,et al.  Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with 1H MRS , 2014, Magnetic Resonance Materials in Physics, Biology and Medicine.

[17]  Zhijiang Liang,et al.  Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. , 2014, The Journal of clinical endocrinology and metabolism.

[18]  T. Kohlmann,et al.  The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population , 2014, Quality of Life Research.

[19]  D. Timmerman,et al.  DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial – study protocol , 2013, BMC Pregnancy and Childbirth.

[20]  C. Cobelli,et al.  Mechanism of Insulin Resistance in Normal Pregnancy , 2013, Hormone and Metabolic Research.

[21]  S. Kirkpatrick,et al.  Update of the Healthy Eating Index: HEI-2010. , 2013, Journal of the Academy of Nutrition and Dietetics.

[22]  Guido Freckmann,et al.  Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use , 2013, Journal of diabetes science and technology.

[23]  A. Icks,et al.  Pre-test of questions on health-related resource use and expenditure, using behaviour coding and cognitive interviewing techniques , 2012, BMC Health Services Research.

[24]  E. Rimm,et al.  Alternative dietary indices both strongly predict risk of chronic disease. , 2012, The Journal of nutrition.

[25]  A. Dyer,et al.  Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria , 2012, Diabetes Care.

[26]  H Boeing,et al.  The European Food Consumption Validation Project: conclusions and recommendations , 2011, European Journal of Clinical Nutrition.

[27]  E. Trolle,et al.  The standardized computerized 24-h dietary recall method EPIC-Soft adapted for pan-European dietary monitoring , 2011, European Journal of Clinical Nutrition.

[28]  A. Tura,et al.  Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[29]  T. Funahashi,et al.  Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determine Glucose Metabolism in Women With a History of Gestational Diabetes Mellitus , 2011, Diabetes Care.

[30]  Z Alfirevic,et al.  Practice guidelines for performance of the routine mid‐trimester fetal ultrasound scan , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[31]  L. Andersen,et al.  Two non-consecutive 24 h recalls using EPIC-Soft software are sufficiently valid for comparing protein and potassium intake between five European centres – results from the European Food Consumption Validation (EFCOVAL) study , 2010, British Journal of Nutrition.

[32]  Gert B. M. Mensink,et al.  Relative validation of a food frequency questionnaire for national health and nutrition monitoring , 2010, Nutrition journal.

[33]  H. Bastian,et al.  Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[34]  Bengt Persson,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[35]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[36]  Dwight J Rouse,et al.  A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.

[37]  J. Dungan,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[38]  David Rodbard,et al.  Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. , 2009, Diabetes technology & therapeutics.

[39]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[40]  Bengt Persson,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[41]  Morten I. Lau,et al.  Eliciting Risk and Time Preferences , 2008 .

[42]  T. Rönnemaa,et al.  Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. , 2007, Diabetes research and clinical practice.

[43]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[44]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[45]  J. Hiller,et al.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. , 2005, The New England journal of medicine.

[46]  Lisa Chasan-Taber,et al.  Development and validation of a Pregnancy Physical Activity Questionnaire. , 2004, Medicine and science in sports and exercise.

[47]  Andrew Briggs,et al.  Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. , 2004, Health economics.

[48]  M. Roden,et al.  The Role of Lipid Accumulation in Liver and Muscle for Insulin Resistance and Type 2 Diabetes Mellitus in Humans , 2004, Reviews in Endocrine and Metabolic Disorders.

[49]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[50]  M. Phillip,et al.  Continuous Glucose Monitoring for the Evaluation of Gravid Women With Type 1 Diabetes Mellitus , 2003, Obstetrics and gynecology.

[51]  M. Phillip,et al.  Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[52]  Charles A. Holt,et al.  Risk Aversion and Incentive Effects , 2002 .

[53]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[54]  Andrea Tura,et al.  Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. , 2002, Diabetes.

[55]  Andrea Mari,et al.  A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .

[56]  E. Riboli,et al.  Standardization of the 24-hour diet recall calibration method used in the European Prospective Investigation into Cancer and Nutrition (EPIC): general concepts and preliminary results , 2000, European Journal of Clinical Nutrition.

[57]  R. Hanson,et al.  Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. , 2000, Diabetes.

[58]  K. Wijma,et al.  Posttraumatic stress disorder after childbirth: a cross sectional study. , 1997, Journal of anxiety disorders.

[59]  A H Briggs,et al.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.

[60]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[61]  F. P. Hadlock,et al.  Estimating fetal age: computer-assisted analysis of multiple fetal growth parameters. , 1984, Radiology.

[62]  M. J. Dauncey,et al.  Assessment of total body fat in infancy from skinfold thickness measurements. , 1977, Archives of disease in childhood.

[63]  S. Pocock,et al.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.

[64]  G. Cassady,et al.  A Noninvasive Approach to Body Composition in the Neonate: Dynamic Skinfold Measurements , 1974, Pediatric Research.

[65]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[66]  B. Ainsworth,et al.  Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ) - Short and long forms , 2005 .

[67]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[68]  E. Brunner,et al.  The Nonparametric Behrens‐Fisher Problem: Asymptotic Theory and a Small‐Sample Approximation , 2000 .

[69]  K. Wijma,et al.  Psychometric aspects of the W-DEQ; a new questionnaire for the measurement of fear of childbirth. , 1998, Journal of psychosomatic obstetrics and gynaecology.